These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
202 related articles for article (PubMed ID: 25499886)
1. Affective symptoms and the overactive bladder - a systematic review. Vrijens D; Drossaerts J; van Koeveringe G; Van Kerrebroeck P; van Os J; Leue C J Psychosom Res; 2015 Feb; 78(2):95-108. PubMed ID: 25499886 [TBL] [Abstract][Full Text] [Related]
2. The impact of overactive bladder on mental health, work productivity and health-related quality of life in the UK and Sweden: results from EpiLUTS. Coyne KS; Sexton CC; Kopp ZS; Ebel-Bitoun C; Milsom I; Chapple C BJU Int; 2011 Nov; 108(9):1459-71. PubMed ID: 21371240 [TBL] [Abstract][Full Text] [Related]
3. Correlation between psychological stress levels and the severity of overactive bladder symptoms. Lai H; Gardner V; Vetter J; Andriole GL BMC Urol; 2015 Mar; 15():14. PubMed ID: 25887525 [TBL] [Abstract][Full Text] [Related]
4. Severe depression and anxiety in women with overactive bladder. Melotti IGR; Juliato CRT; Tanaka M; Riccetto CLZ Neurourol Urodyn; 2018 Jan; 37(1):223-228. PubMed ID: 28407347 [TBL] [Abstract][Full Text] [Related]
5. Prevalence and effect on health-related quality of life of overactive bladder in older americans: results from the epidemiology of lower urinary tract symptoms study. Sexton CC; Coyne KS; Thompson C; Bavendam T; Chen CI; Markland A J Am Geriatr Soc; 2011 Aug; 59(8):1465-70. PubMed ID: 21718275 [TBL] [Abstract][Full Text] [Related]
6. OnabotulinumtoxinA 100 U significantly improves all idiopathic overactive bladder symptoms and quality of life in patients with overactive bladder and urinary incontinence: a randomised, double-blind, placebo-controlled trial. Chapple C; Sievert KD; MacDiarmid S; Khullar V; Radziszewski P; Nardo C; Thompson C; Zhou J; Haag-Molkenteller C Eur Urol; 2013 Aug; 64(2):249-56. PubMed ID: 23608668 [TBL] [Abstract][Full Text] [Related]
7. Is There Any Difference Between Depression and Anxiety in Overactive Bladder According to Sex? A Systematic Review and Meta-Analysis. Melotti IGR; Juliato CRT; Coelho SCA; Lima M; Riccetto CLZ Int Neurourol J; 2017 Sep; 21(3):204-211. PubMed ID: 28954462 [TBL] [Abstract][Full Text] [Related]
8. Daily symptom associations for urinary urgency and anxiety, depression and stress in women with overactive bladder. Mehr AA; Kreder KJ; Lutgendorf SK; Ten Eyck P; Greimann ES; Bradley CS Int Urogynecol J; 2022 Apr; 33(4):841-850. PubMed ID: 34842938 [TBL] [Abstract][Full Text] [Related]
9. The relationship between depression and overactive bladder/urinary incontinence symptoms in the clinical OAB population. Lai HH; Shen B; Rawal A; Vetter J BMC Urol; 2016 Oct; 16(1):60. PubMed ID: 27716241 [TBL] [Abstract][Full Text] [Related]
10. Cues to urinary urgency and urge incontinence: how those diagnosed with overactive bladder syndrome differ from undiagnosed persons. OʼConnell KA; Torstrick A; Victor E J Wound Ostomy Continence Nurs; 2014; 41(3):259-67. PubMed ID: 24805178 [TBL] [Abstract][Full Text] [Related]
11. Overactive bladder and associated psychological symptoms: A possible link to vitamin D and calcium. Abdul-Razzak KK; Alshogran OY; Altawalbeh SM; Al-Ghalayini IF; Al-Ghazo MA; Alazab RS; Halalsheh OM; Sahawneh FE Neurourol Urodyn; 2019 Apr; 38(4):1160-1167. PubMed ID: 30869826 [TBL] [Abstract][Full Text] [Related]
12. Ambulatory urodynamic monitoring of women with overactive bladder syndrome during single voiding cycle. Dokmeci F; Cetinkaya SE; Seval MM; Dai O Eur J Obstet Gynecol Reprod Biol; 2017 May; 212():126-131. PubMed ID: 28355584 [TBL] [Abstract][Full Text] [Related]
13. Understanding the elements of overactive bladder: questions raised by the EPIC study. Irwin DE; Abrams P; Milsom I; Kopp Z; Reilly K; BJU Int; 2008 Jun; 101(11):1381-7. PubMed ID: 18336602 [TBL] [Abstract][Full Text] [Related]
14. Sleep Disturbance and Fatigue Are Associated With More Severe Urinary Incontinence and Overactive Bladder Symptoms. Ge TJ; Vetter J; Lai HH Urology; 2017 Nov; 109():67-73. PubMed ID: 28826875 [TBL] [Abstract][Full Text] [Related]
15. Urgency assessment in the evaluation of overactive bladder (OAB). Starkman JS; Dmochowski RR Neurourol Urodyn; 2008; 27(1):13-21. PubMed ID: 17671973 [TBL] [Abstract][Full Text] [Related]
16. Stimulus-associated urinary urges in overactive bladder syndrome. O'Connell KA; Singer J; Rajan S Neurourol Urodyn; 2018 Jan; 37(1):284-290. PubMed ID: 28464244 [TBL] [Abstract][Full Text] [Related]
17. Effect of bothersome overactive bladder symptoms on health-related quality of life, anxiety, depression, and treatment seeking in the United States: results from EpiLUTS. Milsom I; Kaplan SA; Coyne KS; Sexton CC; Kopp ZS Urology; 2012 Jul; 80(1):90-6. PubMed ID: 22748867 [TBL] [Abstract][Full Text] [Related]
18. Affective symptoms and quality of life in patients with voiding or storage dysfunction: Results before and after sacral neuromodulation: A prospective follow-up study. Jairam R; Drossaerts J; Vrijens D; Leue C; van Kerrebroeck P; van Koeveringe G Neurourol Urodyn; 2018 Jun; 37(5):1801-1808. PubMed ID: 29504634 [TBL] [Abstract][Full Text] [Related]
19. Effects of tolterodine ER on patient-reported outcomes in sexually active women with overactive bladder and urgency urinary incontinence. Rogers RG; Bachmann G; Scarpero H; Jumadilova Z; Sun F; Morrow JD; Guan Z; Bavendam T Curr Med Res Opin; 2009 Sep; 25(9):2159-65. PubMed ID: 19601704 [TBL] [Abstract][Full Text] [Related]
20. Efficacy and tolerability of fesoterodine versus tolterodine in older and younger subjects with overactive bladder: a post hoc, pooled analysis from two placebo-controlled trials. DuBeau CE; Morrow JD; Kraus SR; Creanga D; Bavendam T Neurourol Urodyn; 2012 Nov; 31(8):1258-65. PubMed ID: 22907761 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]